Reporting of results in DART01/05 GICOR

Lancet Oncol. 2015 Jun;16(6):e258. doi: 10.1016/S1470-2045(15)70243-3. Epub 2015 May 27.

Authors

Thomas M Pisansky¹, Vera J Suman², Mack Roach 3rd³, Howard M Sandler⁴

Affiliations

¹ Mayo Clinic, Rochester, MN, 55902, USA. Electronic address: pisansky.thomas@mayo.edu.
² Mayo Clinic, Rochester, MN, 55902, USA.
³ University of California, San Francisco, CA, USA.
⁴ Cedars-Sinai Medical Center, Los Angeles, CA, USA.

PMID: 26065604
DOI: 10.1016/S1470-2045(15)70243-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Adenocarcinoma / therapy*
Androgen Antagonists / administration & dosage*
Antineoplastic Agents, Hormonal / administration & dosage*
Chemoradiotherapy / methods*
Humans
Male
Prostatic Neoplasms / therapy*
Radiotherapy Dosage*
Radiotherapy, Conformal*

Substances

Androgen Antagonists
Antineoplastic Agents, Hormonal